Glass of water and tablets

Fampyra recommended for use on the NHS in Wales

The All Wales Medicines Strategy Group (AWMSG) has recommended Fampyra for use on the NHS in Wales. The drug can help people with MS to improve their walking speed.

This decision means Wales is now the first country in the UK to recommend Fampyra (brand name fampridine) for routine use on the NHS.

What is Fampyra?

Fampyra is taken orally as a tablet. Most people are prescribed one tablet in the morning and one at night. It helps about one in three people who take it.

If this drug works it can speed up walking by about 25%.

What does this decision mean?

The decision means people with MS in Wales should no longer have to pay for the drug privately.

It’s now up to Health Boards in Wales to make sure people can access it. We'll be working with Health Boards in 2020 to make sure access to the drug becomes a reality.

Who can get Fampyra?

Fampyra will be available on the NHS for adults with MS who score between 4-7 on the Expanded Disability Status Scale (EDSS).

What about the rest of the UK?

This decision only applies to Wales.

We hope the pharmaceutical company (Biogen) that makes Fampyra  will now submit the drug for appraisal in Scotland, Northern Ireland and England.

From then, it’s up to the National Institute for Health and Care Excellence (NICE) and the Scottish Medicines Consortium (SMC) to decide whether the drug should be offered across the rest of the UK.

We’ll continue to work across all nations to ensure Fampyra is made available to all those across the UK who could benefit.

A life-changing treatment

Our Cymru director Lynne Hughes said: “It’s fantastic that Fampyra (fampridine) has been approved for use on the NHS in Wales. MS is relentless, painful, and disabling, but this treatment could be life-changing for many of us – making an important difference to walking, energy levels and a person’s ability to manage MS.

“Wales is the first country in the UK to recommend Fampyra, but it’s up to our Health Boards to ensure those who could benefit can access this new drug. We also need appraisal bodies across the UK to follow suit as soon as possible, so everyone with MS can access Fampyra when they need it.”

Get involved

Too many people affected by MS in the UK have to fight for the treatments, services, care and support they need.

Together we can change that.

Join our campaigns community and stand up for people with MS

The next research breakthrough is in reach

Your donation will help stop MS.

  • Please enter an amount

    Our minimum donation is £2, please enter a different amount.

£30could process one blood sample, giving researchers crucial information about genes and the immune system.

£50could pay for an hour on a microscope, so scientists can study cells and tissue in greater detail and improve their understanding of the biology of MS.

£100could pay for half an hour of MRI use, so researchers can monitor the success of clinical trials and understand MS in more detail.

Every penny you give really does take us a step closer to stopping MS. Your donation will make a difference.

  • Please enter an amount

    Our minimum donation is £2, please enter a different amount.

£10a month could pay for lab equipment like microscope slides to study the building blocks of MS

£20a month could pay for lab equipment like petri dishes to grow bacteria important for studying genetics

£30a month could process a blood sample to help us understand what causes MS, so we can stop it in its tracks

Your regular donation means we can keep funding world class MS research with confidence. Together we will stop MS.

MS researcher at work in lab, using a pipette